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6I do not see a widespread use of (robotics) in cardiac surgery in the f
because most cases are really way too complex, and many surgeons sho
learn to do the simple video-assisted surgery with the same quality avoid
the high cost of robotic technology.
Friedrich Wilhelm Mohr, MD, PhD, personal communication, 2006
Assimilation of this (robotic) technology by cardiac programs has been s1
Evelio Rodriguez, MD, and W. Randolph Chitwood, Jr, MD, 2006
Five years ago in an editorial to the Journal entitled “Robotic CardiacSurgery: Quo Vadis?” I expressed serious doubts on the future applicationand general acceptance of this novel technology. These views were based
n the high cost of the equipment itself, the added expenses of the individual
rocedures, the extended operating time, the bizarre concept of long-distance
urgery, and, foremost, the question, What can robotics offer that other simpler 
qually minimally invasive techniques cannot?
In a “counter-editorial,” W. Randolph Chitwood, my good friend and fellow
arolinian, expressed a strong opposing view comparing my stance with that of
aget, who in 1897 prophesied the end of progress in cardiac surgery. The editor
ave me the opportunity to respond, which was brief: Time will tell!
Randy, it looks like time told! Now, 4 years later, we have revisited the issue
f the extent of application of robots in cardiac surgery. Unable to get the data
ny other way, we forwarded questionnaires in July of 2006 to all institutions in
he United States that owned a da Vinci robot (Intuitive Surgical, Sunnyvale,
alif) concerning the yearly volume of robotic heart operations. We were able
o obtain 260 responses (98.2%) to 265 inquiries. On the basis of those
esponses, the following conclusions were drawn: 1) There was indeed an annual
radual increase in the number of da Vinci robots “operating” in the United
tates, with now approximately 25% of all cardiac surgical programs having da
inci robots on their premises. 2) Despite this, however, the number of cardiac
perations performed completely, or much more often partially, with the robotic
echnique showed only a modest yearly increase (400), and the total is now
pproximately 1700 per year. This represents 7.3 operations per available robot
nd approximately 0.5% of all open procedures performed yearly in the United
tates, indicating that many of these machines are either idling or used for other
urposes, primarily in urology. 3) The lion’s share of procedures, more than half
f cardiac procedures, are being done in a handful (10) of institutions. The rest
f the programs, which at one time or another did indeed perform robotic cardiac
urgery, either ceased to do so or perform a few procedures per year. In 2005,
f the “active” cardiac robotic programs, only 12% performed more than 50
obotic interventions yearly. Characteristically, in 2005, the average number of
obotic cardiac procedures done in all but 1 of the 10 institutions that partici-
ated in the initial Food and Drug Administration approval process was a modest
4 cases yearly, with the single “outliner” program performing 60 valve repairs
er year (Figures 1– 4).
See related editorials: Robicsek F. Robotic cardiac surgery: Quo vadis? J Thorac Cardiovasc Surg. 2003;126:
23-4. Chitwood WR Jr. An epistle to Dr. Robicsek. J Thorac Cardiovasc Surg. 2004;127:945-6.
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LDespite the above, there was a seldom-seen upsurge in
ay-media publicity, as well as a plethora of scientific pub-
ications of robotic “firsts”: robotic coronary surgery, ro-
otic valve surgery, robotic pericardiectomy, robotic patent
uct ligation, robotic lead placement, and so forth. During
he last 6 years, more than 200 articles were published on
he subject; approximately 1 article for every 25 robotic
ardiac operations ever performed in the United States: 60
rom the pen of a single author. My favorite article is written
n robotic “myocardial laser revascularization,”2 which suc-
eeded to combine the clinically dubious with the techni-
ally overcomplicated.
Because of the confusing terminology (eg, robotic, to-
ally robotic, robotic assisted, hybrid-robotic), it was diffi-
ult to tell in some cardiac cases whether the technique
pplied was “totally” robotic, probably not more than 15%
igure 1. Cardiac caseload of institutions owning robots in the
nited States (N  265) in 2005.
igure 2. Case load of programs with robots in active use for
ardiac surgery (N 56) in 2005 (260 respondents to 265 surveys). 2
44 The Journal of Thoracic and Cardiovascular Surgery ● Febro 20%. Most articles were case reports, with only a few
ddressing issues such as cost, learning curve, and late
ostoperative outcomes. Those few that did, however, came
o the conclusion that robotic surgery takes longer and is
onsiderably more expensive than conventional cardiac sur-
ical interventions.3
Even if we disregard the $1.0 to $1.5 million purchase
rice for a single robot, there is also the $100 to $140,000
er year service agreement and the $1500 to $2000 cost for
nstruments and accessories per procedure. This increased
xpense could be only partially retrieved by the alleged
odest improvement in the length of postoperative hospital
tay.3 Notably, although a number of centers using robotic-
ssisted technique reported good clinical outcomes, partic-
larly in valve repair,4 the results, however, did not exceed
igure 3. Program volume per year in active robotic cardiac
urgery programs in the United States 1965–2005 (260 respondents
o 265 surveys).
igure 4. Robotic cardiac cases per robot in the United States
002–2005 (260 respondents to 265 surveys).
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Lhose performed in centers of excellence5 using conven-
ional, minimally invasive methods. Chitwood was as mas-
er surgeon before he had the robot, and he is a master
urgeon with the robot as well. It is as simple as that!
The greatest disappointment in robotic cardiac surgery,
owever, is the issue of coronary interventions. We found
nly a scarce number of highly selected cases6 that were
totally robotic,” and most of them were only “robot as-
isted,” that is, conventional bypasses with robotic dissec-
ion of the thoracic artery. Typically, the latter took about
wice as much time and cost than those done by conven-
ional techniques.7
So, why didn’t robotic cardiac surgery become popular?
lthough in the very beginning it generated a lot of enthu-
iasm and institutions virtually were “standing in line” to
urchase robots, especially if the hospital on the other side
f the town already had one, administrators soon realized
hat the robotic technique was too expensive and tied down
perating room space for extended periods. Even after this
xtra expense and time were balanced versus the marketing
spects of attracting patients, especially those who needed
itral valve repair, the initial “robot-friendliness” of hospi-
al administrators soon faded, just to resurge with the mar-
eting success of robotic prostatectomies. The superiority of
obotic prostatectomy over conventional techniques has
een recently challenged as well.8
Today, cardiac surgeons, with the exception of a few
forever” enthusiasts such as Chitwood, seem to be less
nterested in robotic technology than they were 5 years ago.
obotic surgery imposes on the operator’s time and on his
ime. The surgeon, who was able to do several major pro-
edures per day using conventional methods, became weary
f limiting himself or herself to a single robotic case, which
akes extra hours to set up, extra hours to perform, and extra
ours to disengage but provides no extra income. As it
tands now, cardiac robotics seems to be an “overkill,”
eminiscent of the early times of coronary surgery when
any surgeons performed anastomoses using operative mi-
roscopes. It was just too much.
If the future course of cardiac surgery tends toward the
inimally invasive approach, robotics is minimally inva-
ive indeed. To place issues in perspective, the virtues of
obotics should be matched not only against conventional
echniques (sternum-split) but also against varieties of min-
mally invasive techniques (eg, video-assisted, thoraco-
copic). The skin incision will be the same length, the
utcomes will be comparable, but costs and time spent are
uch higher in the “robotic” group. Also why does it have
o be “tele”-robotic? In other words, why does anybody
refer such a grotesque situation? The operating room is
ully set up for conventional surgery, the usual instruments
re sterile and on the table, the nurse is gowned, a secondary
urgeon is scrubbed and at the patient’s side, and then an
4
The Journal of Thoracicnseen manipulator “pulls the strings” from another room.
he issue of “long-distance telerobotics”9 makes even less
ense. Show me an institution that has a million-plus dollar
obot but no cardiac surgeon on board? Buy the patient a
lane ticket!9
The future of cardiac robotic surgery is uncertain. Log-
cally, the next step in robotics should be preprogrammed
nterventions. These may indeed work to remove static brain
esions, but it is unlikely they will find application in the
eart. Unlike in prostatic surgery, where robotic business is
booming,” in open procedures where the viability of the
eart has to be maintained during manipulation by cardio-
ulmonary bypass, a similar upsurge of robotics is highly
nlikely. However, if both the industry and the surgeons
ould “reprogram” themselves to perfect small, patient-
ide, high-technology manipulative arms, suitable to be
sed in conjunction with thoracoscopy, they would get rid
f the huge teleconsole and the odd idea of “long-distance
urgery.” Elements of robotics could indeed be part of the
uture technology of minimally invasive cardiac inventions.
he proper way, however, to proceed in this endeavor is not
o flood the market with billions of dollars worth of hard-
are, most of it already obsolete, but to limit their use to a
ew centers with sincere professional interest, until in well-
ontrolled trials, the technology proves itself economically
ound as well as clinically superior to that which we already
ave today.
The author thanks Howell C. Sasser, PhD, for the statistical
orkup and Lisa Freeman for the technical conduction of the
urvey.
obotics
Very
fashionable
stance
Do your prostate
long-distance
But if you want
save a
life
Trust a surgeon
with a
knife
Anonymous Hungarian Poet
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